Life-time estrogen exposure and cognitive functioning in later life

Psychoneuroendocrinology

Volumn 34, Issue 2, 2009, Pages 287-298

  Ryan, Joanne ^a,b,c   Carrière, Isabelle ^a,b   Scali, Jacqueline ^a,b   Ritchie, Karen ^a,b   Ancelin, Marie Laure ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognition; Dementia; Estrogen; Hormone therapy; Lifetime exposure

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FLUENCY DISORDER; FOLLOW UP; HORMONAL THERAPY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REPRODUCTION; TASK PERFORMANCE; VERBAL COMMUNICATION; VERBAL MEMORY; VISUAL MEMORY;

AGED; AGED, 80 AND OVER; COGNITION; DEMENTIA; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MEMORY; REPRODUCTIVE HISTORY;

EID: 58249136399     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.09.008     Document Type: Article

References (73)

1. American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Association.
2. Ancelin M.L., and Ritchie K. Lifelong endocrine fluctuations and related cognitive disorders. Curr. Pharm. Des. 11 (2005) 4229-4252
3. Ancelin M.L., Artero S., Portet F., Dupuy A.M., Touchon J., and Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332 (2006) 455-459
4. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R., Dartigues J.F., Kragh-sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-lage J.M., Stijnen T., and Hofman A. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53 (1999) 1992-1997
5. Apter D., and Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J. Clin. Endocrinol. Metab. 57 (1983) 82-86
6. Apter D., Reinila M., and Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int. J. Cancer 44 (1989) 783-787
7. Bean J.A., Leeper J.D., Wallace R.B., Sherman B.M., and Jagger H. Variations in the reporting of menstrual histories. Am. J. Epidemiol. 109 (1979) 181-185
8. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3 (2002) 433-442
9. Benton A.L. Manuel pour l'application du test de retention visuelle. Applications cliniques et experimentales (1965), Centre de Psychologie Appliquee, Paris
10. Bernstein L., and Ross R.K. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15 (1993) 48-65
11. Bernstein L., Pike M.C., Ross R.K., Judd H.L., Brown J.B., and Henderson B.E. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J. Natl. Cancer Inst. 74 (1985) 741-745
12. Bernstein L., Depue R.H., Ross R.K., Judd H.L., Pike M.C., and Henderson B.E. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J. Natl. Cancer Inst. 76 (1986) 1035-1039
13. Britt K., Ashworth A., and Smalley M. Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer 14 (2007) 907-933
14. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13 (2002) 831-838
15. Colucci M., Cammarata S., Assini A., Croce R., Clerici F., Novello C., Mazzella L., Dagnino N., Mariani C., and Tanganelli P. The number of pregnancies is a risk factor for Alzheimer's disease. Eur. J. Neurol. 13 (2006) 1374-1377
16. Commenges D., Letenneur L., Joly P., Alioum A., and Dartigues J.F. Modelling age-specific risk: application to dementia. Stat. Med. 17 (1998) 1973-1988
17. Dorgan J.F., Reichman M.E., Judd J.T., Brown C., Longcope C., Schatzkin A., Campbell W.S., Franz C., Kahle L., and Taylor P.R. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 381-386
18. Dubois B. L'epreuve des cinq mots. Neurol. Psychiatr. Geriatr. 1 (2001) 40-42
19. Dufouil C., Richard F., Fievet N., Dartigues J.F., Ritchie K., Tzourio C., Amouyel P., and Alperovitch A. APOE genotype, cholesterol level, lipid-lowering treatment and dementia. Neurology 64 (2005) 1531-1538
20. Dunkin J., Rasgon N., Wagner-Steh K., David S., Altshuler L., and Rapkin A. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology 30 (2005) 284-296
21. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., and Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. JAMA 291 (2004) 2959-2968
22. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
23. Gao S., Hendrie H.C., Hall K.S., and Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55 (1998) 809-815
24. Geerlings M.I., Ruitenberg A., Witteman J.C., Van Swieten J.C., Hofman A., Van Duijn C.M., Breteler M.M., and Launer L.J. Reproductive period and risk of dementia in postmenopausal women. JAMA 285 (2001) 1475-1481
25. Grady D., Yaffe K., Kristof M., Lin F., Richards C., and Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the heart and estrogen/progestin replacement study. Am. J. Med. 113 (2002) 543-548
26. Grodstein F., Chen J., Pollen D.A., Albert M.S., Wilson R.S., Folstein M.F., Evans D.A., and Stampfer M.J. Postmenopausal hormone therapy and cognitive function in healthy older women. J. Am. Geriatr. Soc. 48 (2000) 746-752
27. Henderson V.W., and Sherwin B.B. Surgical versus natural menopause: cognitive issues. Menopause 14 (2007) 572-579
28. Henderson V.W., Guthrie J.R., Dudley E.C., Burger H.G., and Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60 (2003) 1369-1371
29. Hogervorst E., Yaffe K., Richards M., and Huppert F. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database. Syst. Rev. (2002) CD0031
30. Hogervorst E., Yaffe K., Richards M., and Huppert F. Hormone replacement therapy to maintain cognitive function in women with dementia (cochrane review). Cochrane Database Syst. Rev. (2002) CD0037
31. Isaacs B., and Kennie A.T. The Set Test as an aid to the detection of dementia in old people. Br. J. Psychiatry 45 (1973) 957-962
32. Kalache A., Maguire A., and Thompson S.G. Age at last full-term pregnancy and risk of breast cancer. Lancet 341 (1993) 33-36
33. Kang J.H., Weuve J., and Grodstein F. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology 63 (2004) 101-107
34. Katz S., Ford A.B., Moskowitz R.W., and Jaffee M.W. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 195 (1963) 94-99
35. Kok H.S., Kuh D., Cooper R., van der Schouw Y.T., Grobbee D.E., Wadsworth M.E., and Richards M. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause 13 (2006) 19-27
36. Kuh D., Butterworth S., Kok H., Richards M., Hardy R., Wadsworth M.E., and Leon D.A. Childhood cognitive ability and age at menopause: evidence from two cohort studies. Menopause 12 (2005) 475-482
37. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
38. Leblanc E.S., Janowsky J., Chan B.K., and Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285 (2001) 1489-1499
39. Lebrun C.E., van der Schouw Y.T., de Jong F.H., Pols H.A., Grobbee D.E., and Lamberts S.W. Endogenous oestrogens are related to cognition in healthy elderly women. Clin. Endocrinol. (Oxford) 63 (2005) 50-55
40. Low L.F., Anstey K.J., Jorm A.F., Rodgers B., and Christensen H. Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60-64 years. Climacteric 8 (2005) 380-389
41. MacLennan A.H., Henderson V.W., Paine B.J., Mathias J., Ramsay E.N., Ryan P., Stocks N.P., and Taylor A.W. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13 (2006) 28-36
42. MacMahon B., Trichopoulos D., Brown J., Andersen A.P., Aoki K., Cole P., deWaard F., Kauraniemi T., Morgan R.W., Purde M., Ravnihar B., Stromby N., Westlund K., and Woo N.C. Age at menarche, probability of ovulation and breast cancer risk. Int. J. Cancer 29 (1982) 13-16
43. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 138 (2006) 1027-1030
44. Maki P., and Hogervorst E. The menopause and HRT. HRT and cognitive decline. Best Pract. Res. Clin. Endocrinol. Metab. 17 (2003) 105-122
45. McLay R.N., Maki P.M., and Lyketsos C.G. Nulliparity and late menopause are associated with decreased cognitive decline. J. Neuropsychiatr. Clin. Neurosci. 15 (2003) 161-167
46. Musey V.C., Collins D.C., Brogan D.R., Santos V.R., Musey P.I., Martino-Saltzman D., and Preedy J.R. Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J. Clin. Endocrinol. Metab. 64 (1987) 111-118
47. Nappi R.E., Sinforiani E., Mauri M., Bono G., Polatti F., and Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol. Obstet. Invest. 47 (1999) 29-36
48. National Heart, L., Blood Institute 1998. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults The Evidence Report. In: Publication N. (Ed.).
49. Paganini-Hill A., and Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140 (1994) 256-261
50. Pefanco M.A., Kenny A.M., Kaplan R.F., Kuchel G., Walsh S., Kleppinger A., and Prestwood K. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J. Am. Geriatr. Soc. 55 (2007) 426-431
51. Petitti D.B., Crooks V.C., Chiu V., Buckwalter J.G., and Chui H.C. Incidence of dementia in long-term hormone users. Am. J. Epidemiol. 167 (2008) 692-700
52. Ptok U., Barkow K., and Heun R. Fertility and number of children in patients with Alzheimer's disease. Arch. Women Ment. Health 5 (2002) 83-86
53. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Measure. 1 (1977) 385-401
54. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., and Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. JAMA 289 (2003) 2663-2672
55. Rasgon N.L., Magnusson C., Johansson A.L., Pedersen N.L., Elman S., and Gatz M. Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study. Psychoneuroendocrinology 30 (2005) 558-567
56. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Percept. Motor Skill 8 (1965) 271-276
57. Resnick S.M., Metter E.J., and Zonderman A.B. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?. Neurology 49 (1997) 1491-1497
58. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., and Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 91 (2006) 1802-1810
59. Ritchie K., Artero S., Beluche I., Ancelin M.L., Mann A., Dupuy A.M., Malafosse A., and Boulenger J.P. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br. J. Psychiatry 184 (2004) 147-152
60. Ritchie K., Carriere I., de Mendonca A., Portet F., Dartigues J.F., Rouaud O., Barberger-Gateau P., and Ancelin M.L. The neuroprotective effects of caffeine: a prospective population study (the three city study). Neurology 69 (2007) 536-545
61. Ryan J., Scali J., Carriere I., Ritchie K., and Ancelin M.L. Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int. Psychogeriatr. 20 (2008) 47-56
62. Ryan, J., Carriere, I., Scali, J., Ritchie, K., Ancelin, M.L., 2008b. Lifetime hormonal factors may predict late-life depression in women. Int. Psychogeriatr June 5: 1-16 [Epub ahead of print].
63. Schiff R., Bulpitt C.J., Wesnes K.A., and Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology 30 (2005) 309-315
64. Shaywitz S.E., Naftolin F., Zelterman D., Marchione K.E., Holahan J.M., Palter S.F., and Shaywitz B.A. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 10 (2003) 420-426
65. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr. Rev. 24 (2003) 133-151
66. Sherwin B.B., and Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 29 (2008) 88-113
67. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
68. Smith C.A., Mccleary C.A., Murdock G.A., Wilshire T.W., Buckwalter D.K., Bretsky P., Marmol L., Gorsuch R.L., and Buckwalter J.G. Lifelong estrogen exposure and cognitive performance in elderly women. Brain. Cogn. 39 (1999) 203-218
69. Smith Y.R., Giordani B., Lajiness-O'Neill R., and Zubieta J.K. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil. Steril. 76 (2001) 1101-1107
70. Trapido E.J. Age at first birth, parity, and breast cancer risk. Cancer 51 (1983) 946-948
71. WHO 2000. World health organising collaborating centre for drug statistics methodology. Guidelines for ATC Classification and DDD Assignment.
72. Yaffe K., Sawaya G., Lieberburg I., and Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279 (1998) 688-695
73. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., and Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache county study. JAMA 288 (2002) 2123-2129